Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue    
Revenue $ 18,397 $ 13,896
Costs and expenses    
Selling, general and administrative 18,949 22,540
Research and development 216 146
Depreciation and amortization 9,655 7,391
Operating loss (16,901) (27,136)
Gain on derivatives 1,531 8,140
Income on equity method investment 529 257
Interest income 435 0
Interest expense (1,853) (1,255)
Other (expense) income, net (943) 2
Loss before income taxes (17,202) (19,992)
Income tax expense (113) 0
Net loss (17,315) (19,992)
Other comprehensive income 0 0
Total comprehensive loss $ (17,315) $ (19,992)
Basic:    
Net loss per share of common stock (in dollars per share) $ (0.14) $ (0.17)
Diluted:    
Net loss per share of common stock, diluted (in dollars per share) $ (0.14) $ (0.17)
Imagery & software analytical services    
Revenue    
Revenue $ 15,760 $ 7,370
Costs and expenses    
Costs excluding depreciation and amortization 3,699 3,578
Professional & engineering services    
Revenue    
Revenue 2,637 6,526
Costs and expenses    
Costs excluding depreciation and amortization $ 2,779 $ 7,377